Over the past several decades, organizations have invested vast resources in data infrastructure to improve decision success, but the results are mixed. A new approach called “decision-back” flips the ...

In clinical trials, the initial step typically involves assessing a new drug's toxicity profile, aiming to identify a tolerable dose level for subsequent studies. In phase I trials, the primary ...